ライフサイエンスコーパス: nonepithelial

1 ssibility that inappropriate expression of a nonepithelial cadherin by an epithelial cell might also

2 other systems, inappropriate expression of a nonepithelial cadherin, such as N-cadherin, by an epithe

3 ial cells; i.e., inadvertent expression of a nonepithelial cadherin.

4 explored the possibility that expression of nonepithelial cadherins may be correlated with increased

5 pithelial cell adenocarcinomas as well as in nonepithelial cancer cell lines, as well as in hematolog

6 ceeds in at least two steps: Conversion of a nonepithelial cell into an epithelial sheet followed by

7 ll foster meaningful investigations into how nonepithelial cell populations are controlled during lun

8 The corneal stromal cell is the first nonepithelial cell type shown to synthesize maspin.

9 e growth factors, cytokines and a variety of nonepithelial cell types including endothelial cells, im

10 Of interest, nonepithelial cell types such as vascular smooth muscle,

11 Low gene delivery to nonepithelial cell types was directly correlated to a de

12 gpen was absent or greatly attenuated in the nonepithelial cell types we examined, including fibrobla

13 host and enhances inflammatory signaling in nonepithelial cell types, which subsequently promotes le

14 elial cells to undergo EMT in vivo to become nonepithelial cell types.

15 stochemistry demonstrated VZV replication in nonepithelial cell types.

16 rular volume (IGV) and numbers of podocytes, nonepithelial cells (NECs; tuft cells other than podocyt

17 lls were separated from normal epithelia and nonepithelial cells by dissection and bivariate cytokera

18 Studies on nonepithelial cells have shown that this protein is loca

19 t BRCA1 deficiency in epithelial and certain nonepithelial cells may result in combined effects of ab

20 al species, but could not be detected in the nonepithelial cells we examined.

21 pression in hepatocytes, cholangiocytes, and nonepithelial cells within the liver.

22 In nonepithelial cells, activation of phospholipase C (PLC)

23 we demonstrate that type I IFNs act through nonepithelial cells, including macrophages, to promote i

24 an aPKC targeting and specificity factor in nonepithelial cells, our results reveal that it performs

25 h as those of the kidney tubule, but also on nonepithelial cells, such as chondrocytes, fibroblasts,

26 s the heat shock protein (hsp72) response in nonepithelial cells, the possibility that mesalamine con

27 nstration of the presence of this protein in nonepithelial cells.

28 ns of AA transporters in both epithelial and nonepithelial cells.

29 ible Siglec-F ligands by lung epithelial and nonepithelial cells.

30 keratins as has been shown for SV40 in other nonepithelial cells.

31 Expression of PGLYRP2 was not induced in nonepithelial cells.

32 ely to be regulated by other Ets proteins in nonepithelial cells.

33 ions in all tissues, to the exclusion of all nonepithelial cells.

34 annel (ENaC) currents in many epithelial and nonepithelial cells.

35 rved in a number of different epithelial and nonepithelial cells.

36 rols, suggesting that CCL22 is secreted by a nonepithelial component of the microenvironment.

37 lize with epithelial adherens junctions, and nonepithelial-derived proteases have junctional proteins

38 Low dose level (relative risk = 3.418) and nonepithelial histology (relative risk = 2.336) were ind

39 this anticolitic activity is independent of nonepithelial immune VDR actions.

40 thelial stem cells, but the role of LRIG1 in nonepithelial intestinal cells has not been identified.

41 The OSMR is expressed in nonhematopoietic, nonepithelial intestinal stromal cells, which respond to

42 a novel interaction for alpha(E)beta(7) at a nonepithelial location.

43 on of hnRNP A2/B1 may play a role in EMT, in nonepithelial lung cancer cell lines A549 and H1703, thr

44 t, lung, ovarian, and bladder cancers) and 5 nonepithelial malignancies (lymphoma, mesothelioma, medu

45 mosomal instability and cancer, particularly nonepithelial malignancies typical of Werner syndrome.

46 lay a role in homotypic interactions between nonepithelial migratory myocytes during trabecular forma

47 AHNAK is predominantly nuclear in cells of nonepithelial origin, but is cytoplasmic or associated w

48 he RNase IIIb domain were found in 30 of 102 nonepithelial ovarian tumors (29%), predominantly in Ser

49 ced the whole transcriptomes or exomes of 14 nonepithelial ovarian tumors and noted closely clustered

50 Mutation carriers are at risk for nonepithelial ovarian tumors, notably sex cord-stromal t

51 he RNase IIIb domain of DICER1 are common in nonepithelial ovarian tumors.

52 er tissue contains responsive sites that are nonepithelial, probably vascular, or perhaps stromal.

53 ymphoma, melanoma, and lung, pancreatic, and nonepithelial skin cancers (higher during function inter

54 ip cancer (HR, 3.4; 95% CI, 2.0 to 6.0), and nonepithelial skin cancers (HR, 3.8; 95% CI, 2.5 to 5.8)

55 x, growth factors, and cytokines produced by nonepithelial stromal cells.

56 on of p63 led to up-regulation of markers of nonepithelial tissues (mesenchyme and neural tissue) in

57 ntribute to transmembrane Cl(-) transport in nonepithelial tissues such as the heart.

58 e essential for life, but lumen formation in nonepithelial tissues such as the vascular system or hea

59 ession when compared to other epithelial and nonepithelial tissues, with several antioxidant, detoxif

60 nels are found in other epithelia as well as nonepithelial tissues.

61 high levels on colon, breast, lung, and some nonepithelial tumors.

62 stabilization in several patients who had a nonepithelial type of malignancy.

63 e anticolitic contribution of epithelial and nonepithelial VDR signaling is unknown.

64 nd development of organoid cultures, whereas nonepithelial Wnt signals could provide a secondary phys